葵花药业：2025年上半年净利润8130.99万元，同比下降83.28%

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its operational performance [1]. Financial Performance - The company's operating revenue for the first half of 2025 was 1.31 billion yuan, representing a year-on-year decrease of 48.17% [1]. - The net profit for the same period was 81.31 million yuan, reflecting a year-on-year decline of 83.28% [1].